The enormous waste of resources due to red tape described by Polly Toynbee (Business is haunted by Brexit – and this safety mark fiasco is its latest nightmare, 4 August) is not just confined to British business – it has severely affected UK research in the area of medical devices.
Scientists need to partner with manufacturers in order to get these devices out of the lab and into the clinic. But we and others have experienced our industrial partners withdrawing support and pulling out of agreements because it has been simply too costly to embark on double certification of potential products.
